Clinical Trials Logo

Clinical Trial Summary

The goal of this study is two-fold: to establish a tissue banking respository (defined as blood, urine, soft tissue, tumor specimen, and normal tissue from areas surrounding tumor specimens), and to prospectively assess health related quality of life (QOL) over time in patients with a pathologically confirmed diagnosis of neoplasia receiving radiotherapy or photodynamic therapy (PDT)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Neoplasms
  • Patients With Pathologically Confirmed Neoplasia That Have Been
  • Selected for Definitive Photodynamic Therapy, Proton, or Photon Radiation Therapy

NCT number NCT01577251
Study type Observational
Source Abramson Cancer Center at Penn Medicine
Contact Jay Dorsey, MD, PhD
Phone 855-216-0098
Email PennCancerTrials@emergingmed.com
Status Recruiting
Phase
Start date June 2008
Completion date December 2030